A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

Clinical trial NCT03782207 · COMPLETED

Trial details

NCT number: NCT03782207
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Urothelial Carcinoma Non-Small Cell Lung Cancer Small Cell Lung Cancer Hepatocellular Carcinoma

Start date: 2019-02-07
Primary completion: 2026-07-31
Enrollment: 2756

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.